Symbiotec: Global API manufacturer, specializing in Cortico-Steroids & Steroid-Hormone APIs.

Reset all filters
01 2Symbiotec Pharmalab Private Limited
02 3Coral Drugs Private Limited
03 1Farmabios S.p.A.
04 1VAMSI LABS LIMITED.
05 2Aarti Pharmalabs Limited
06 1AX Pharmaceutical Corp
07 2Cipla Ltd.
08 1Curia Spain S.A.U.
09 1Fagron Inc
10 1Henan Lihua Pharmaceutical Co Ltd
11 2Hovione FarmaCiencia SA
12 4Industriale Chimica s.r.l.
13 1LETCO MEDICAL, LLC
14 1Medisca Inc.
15 1NEWCHEM SPA
16 1Professional Compounding Centers of America
17 1Professional Compounding Centers of America dba PCCA
18 1STERLING SPA
19 1SYMBIOTICA SPECIALITY INGREDIENTS SDN.BHD
20 2Sicor de Mexico S.A. de C.V
21 2Sterling S.p.A.
22 1zhejiang xianju pharmaceutical co., Ltd.
Reset all filters
01 4MOMETASONE FUROATE
02 1MOMETASONE FUROATE MICRONIZED
03 2MOMETASONE FUROATE MONOHYDRATE
04 17Mometasone Furoate
05 7Mometasone Furoate Monohydrate
06 1Mometasone furoate
07 1mometasone furoate
Reset all filters
01 2China
02 1Germany
03 10India
04 8Italy
05 1Malaysia
06 2Mexico
07 1Netherlands
08 2Portugal
09 3U.S.A
10 2United Kingdom
11 1Blank
NDC Package Code : 22552-0002
Start Marketing Date : 2017-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49076-5603
Start Marketing Date : 2025-08-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46439-8781
Start Marketing Date : 2025-02-19
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
MOMETASONE FUROATE MONOHYDRATE
NDC Package Code : 66412-0686
Start Marketing Date : 2025-07-15
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-0220
Start Marketing Date : 2006-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
MOMETASONE FUROATE MONOHYDRATE
NDC Package Code : 22552-0021
Start Marketing Date : 2011-05-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
MOMETASONE FUROATE MONOHYDRATE
NDC Package Code : 49076-5701
Start Marketing Date : 2025-10-18
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
MOMETASONE FUROATE MONOHYDRATE
NDC Package Code : 49076-5702
Start Marketing Date : 2025-10-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
MOMETASONE FUROATE MONOHYDRATE
NDC Package Code : 15308-2710
Start Marketing Date : 2006-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24002-0004
Start Marketing Date : 2009-08-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

22
PharmaCompass offers a list of Mometasone Furoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mometasone Furoate manufacturer or Mometasone Furoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mometasone Furoate manufacturer or Mometasone Furoate supplier.
PharmaCompass also assists you with knowing the Mometasone Furoate API Price utilized in the formulation of products. Mometasone Furoate API Price is not always fixed or binding as the Mometasone Furoate Price is obtained through a variety of data sources. The Mometasone Furoate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ASMANEX TWISTHALER manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ASMANEX TWISTHALER, including repackagers and relabelers. The FDA regulates ASMANEX TWISTHALER manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ASMANEX TWISTHALER API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of ASMANEX TWISTHALER manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A ASMANEX TWISTHALER supplier is an individual or a company that provides ASMANEX TWISTHALER active pharmaceutical ingredient (API) or ASMANEX TWISTHALER finished formulations upon request. The ASMANEX TWISTHALER suppliers may include ASMANEX TWISTHALER API manufacturers, exporters, distributors and traders.
click here to find a list of ASMANEX TWISTHALER suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing ASMANEX TWISTHALER as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for ASMANEX TWISTHALER API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture ASMANEX TWISTHALER as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain ASMANEX TWISTHALER and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a ASMANEX TWISTHALER NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of ASMANEX TWISTHALER suppliers with NDC on PharmaCompass.
We have 19 companies offering ASMANEX TWISTHALER
Get in contact with the supplier of your choice: